Radiopharmaceutical Production

Slides:



Advertisements
Similar presentations
Radiopharmaceutical Production
Advertisements

Radiopharmaceutical Production
Radiopharmaceutical Production
ICH Q4B Regulatory Acceptance of Analytical Procedures and/or Acceptance Criteria (RAAPAC) Overview and Update Robert H. King, Sr. Office of Pharmaceutical.
Radiopharmaceutical Production
Radiopharmaceutical Production Filter integrity test STOP.
Finished Pharmaceutical Product Specifications
Sultan Ghani WHO Prequalification Programme of Priority Essential Medicines, October 2010, Abu Dhabi, U.A.E. Experience of Pre-Qualification Program.
Radiopharmaceutical Production
World Health Organization
The concept of Quality ● Quality means those features of products which meet customers needs and thereby provide customer satisfaction. This meaning is.
Transition to Inspections: USP, 21 CFR 212, And Beyond? Panel Discussion Ravi S. Harapanhalli, Ph.D Louis Marzella, MD Ravindra Kasliwal, Ph.D Wendy Sanhai,
Quality control of raw materials In-process control
Radiopharmaceutical Production
Quality Control of Radiopharmaceuticals
Distributed Manufacturing via the SNM Multicenter FLT IND Part II SNM Midwinter Clinical Trials Network Albuquerque, New Mexico February 2, 2010 Sally.
Radiopharmaceutical Production
VALIDATION OF RAW MATERIALS
1 FDA Thailand By HIV Module/Marketing Group Mr. Manaswee Arayasiri.
Quality Control of Radiopharmaceuticals
Presented by: Karen Ginsbury For IFF, Denmark March 2012.
Radiopharmaceutical Production
Achieving and Demonstrating “Quality-by-Design” with Respect to Drug Release/dissolution Performance for Conventional or Immediate Release Solid Oral Dosage.
Radiopharmaceutical Production Quality Control Testing Visual Inspection STOP.
© AL IPA/EDQM/IDMA Symposium 2007, All rights reserved The Ph. Eur. policy on Reference standards Dr Andrea Lodi Deputy Head, Laboratory Department, EDQM,
Overview of FDA's Regulatory Framework for PET Drugs
RAISING THE BAR Meeting CSA Guidelines And Preparing for Health Canada
Product Development Chapter 6. Definitions needed: Verification: The process of evaluating compliance to regulations, standards, or specifications.
Overview of USP Chapter for IND and RDRC Regulated PET Compounding Distributed Manufacturing of PET Radiopharmaceuticals for Multi-Center Clinical Trials.
DMF Procedures and Communication between API, FP Manufacturers and Regulatory Authorities Jean-Louis ROBERT National Health Laboratory L – 1011 LUXEMBOURG.
Principles of quality control of registered medicines, non- registered medicines and counterfeits of medical products Jean-Marc Spieser, Head of Department.
Mechanical Integrity Written Procedures. Lesson Objectives  Describe Required Written Procedures for Establishing an MI Program  List Acceptable Sources.
Quality control Lecture 1.
Leukocyte-Reduced Blood Components Lore Fields MT(ASCP)SBB Consumer Safety Officer, DBA, OBRR, CBER September 16, 2009.
Demonstrably Difficult to Compound Drug Products Kathleen Anderson, Pharm. D. Division of Prescription Drug Compliance and Surveillance Office of Compliance.
Current issues and challenges in the development of IP monographs Dr. G.N. Singh Secretary-cum-Scientific Director Indian Pharmacopoeia Commission Ghaziabad.
Radiopharmaceutical Production Quality Control Testing Product Stability STOP.
Overview of FDA's Regulatory Framework for PET Drugs
FAO/WHO Codex Training Package Module 4.3 FAO/WHO CODEX TRAINING PACKAGE SECTION FOUR – SCIENTIFIC BASIS FOR CODEX WORK 4.3 What is JECFA?
Radiopharmaceutical Production Sub STOP. Radionuclidic purity Radionuclidic purity may be defined as the fraction of total radioactivity that is present.
INSPECTION AND ACCEPTANCE CRITERIA. PRODUCT CONFORMANCE Dimensional conformance - within tolerances as defined on product drawing Dimensional conformance.
© AL IPA/EDQM/IDMA Symposium 2007, All rights reserved The Ph. Eur. policy on impurities Dr Andrea Lodi Deputy Head, Laboratory Department, EDQM, Council.
Material Safety Data Sheets Location of MSDS Must accompany every shipment of hazardous substance and must be available to you on the job site.
1 FDA Guidance for Industry: ANDAs: Impurities in Drug Substances Published by US FDA’s Center for Drug Evaluation and Research June 2009.
Healthcare Safety and Standard Precautions Competencies 7-8.
Windows SharePoint 2007 Introduction. What is Microsoft SharePoint 2007? Microsoft SharePoint 2007 is the central information sharing and collaboration.
Radiopharmaceutical Production
Radiopharmaceutical Production Radionuclidic identity STOP.
Radiopharmaceutical Production
Radiopharmaceutical Production
Pharmaceutical Quality Control & current Good Manufacturing Practice PHT 436 Lecture 8 1.
Second Meeting of the FDA/ACPS Process Analytical Technology: Closing Remarks Ajaz S. Hussain, Ph.D. Deputy Director Office of Pharmaceutical Sciences.
Radiopharmaceutical Production Radioassay STOP. Radiopharmaceutical Production Radioassay Example STOP Radioassay Acceptance Criteria: The product label.
SEMINAR ON PRESENTED BY BRAHMABHATT BANSARI K. M. PHARM PART DEPARTMENT OF PHARMACEUTICS AND PHARMACEUTICAL TECHNOLGY L. M. COLLEGE OF PHARMACY.
Radiopharmaceutical Production
7-A Block R III, Johar Town, Lahore, Pakistan SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTRE References Conclusion.
BSA 385 Week 4 Individual Assignment Frequent Shopper Program Part 3 For the items specified in the technical architecture document developed for the Frequent.
GMP -Regulatory Perspective Sukanti Borkar Abbott India Ltd.
REGULATORY REQUIREMENTS FOR PREFORMULATION STUDIES
Radiopharmaceutical Production
Pharmaceutical Quality Control & current Good Manufacturing Practice
12 Safe Maintenance Rules
Radiopharmaceutical Production
What are they preserving?
Radiopharmaceutical Production
Radiopharmaceutical Production
Radiopharmaceutical Production
Radiopharmaceutical Production
Radiopharmaceutical Production
SID & GP MINPROMTORG OF RUSSIA Corporate Communication Center
Presentation transcript:

Radiopharmaceutical Production Quality Control STOP

Quality Control Testing Quality Control (QC) Contents FDG must conform to various quality attributes of purity, efficacy and safety prior to being considered suitable for patient use. Customarily, monographs contained within the National Pharmacopoeia are the official reference source of quality specifications for a pharmaceutical product. PET radiopharmaceuticals, including FDG, being the emerging products, are likely not incorporated into many National Pharmacopoeias. In such a situation, FDG quality specifications detailed in the International Pharmacopoeia (IP), the European Pharmacopoeia (Ph. Eur.) or the United States Pharmacopoeia (USP) may serve as valuable reference sources for establishing the FDG quality specifications. Reviews of Procedure Examples of Procedures Literature STOP

Review of Procedures The quality control of PET radiopharmaceuticals is one of the most important parts of production. These tests ensure that the quality assurance program is working and that you are producing a safe and effective product. This tutorial describes some example procedures that may be used in the testing of PET radiopharmaceuticals. These procedures may not be acceptable in some situations. Other processes and procedures that are not described in this tutorial may also be acceptable A discussion of the various procedures and requirements may be found in the following sources. Reviews of QC procedures Hung 2004 Yu 2006 Shankar 2008

Examples of Procedures To learn more about each of the quality control tests required for FDG, follow the links below to a discussion and example demonstration of the tests Radionuclidic identity Radiochemical identity Visual Inspection Radionuclidic purity Radiochemical purity Radioassay Chemical Purity Residual solvents Phase transfer catalyst Chloro-deoxyglucose [18F]FDM Pyrogen Sterility Filter integrity Product stability

Literature The following links will lead you to the web sites of the major documents on the quality control tests required by differenct organizations. International Pharmacopoeia (IP), http://www.who.int/medicines/publications/pharmacopoeia/overview/en/index.html European Pharmacopoeia (Ph. Eur.) http://www.edqm.eu/en/Work-ProgrammeStatus-607.html United States Pharmacopoeia (USP) http://www.usp.org/ A discussion of these tests can be found in the following papers. Reviews of QC procedures Hung 2004 Yu 2006 Shankar 2008

Return to Main Menu